ARCH has office throughout the United States and Europe. They limit their investments strictly to seed and early stage investments in the industries they work within, but will offer additional growth funds to companies they have a strong relationship with.
Since their investments are highly centered in the sciences, they prefer to team with companies that are cofounded by experienced entrepreneurs and highly regarded scientists with a track record for noteworthy research. Though few outside their industries of choice would recognize many of their investments, they have an excellent portfolio to boast particularly in the area of biotech and development including VBI Vaccines, Pulmatrix, Chiasma, Belleophon Therapeutics, Juno Therapeutics, Illumina, Aviron, Alnylam Pharmaceuticals, Kythera Biopharmaceuticals, Receptos, Agios Pharmaceuticals, Array BioPharma, Ahura Scientific, ALIS, MicroOptical Devices, Adolor, Everyday Learning, Innovalight, and R2 Technology.
Founded: 1986
Funds raised / currently managed: ~1.8 billion
Focus industries: Commercial services, healthcare devices/supplies, pharmaceuticals and biotechnology.
Other Offices:
Seattle
- Address: 999 Third Ave., Suite 3400, Seattle, WA 98104
- Phone: 206 674 8712
- Fax: 206 674 3026
San Francisco
- Address: 1700 Owens St., Suite 535, San Francisco, CA 94158
- Phone: 415 565 7103
Austin
- Address: 5001 Plaza on the Lake Blvd., Suite 103, Austin, TX 78746
- Phone: 512 795 5830
- Fax: 512 795 5849